DuPont De Nemours is listed as a top gainer among S&P 500 components, linked to recent earnings reports or positive business developments. Financial result announcements drive volatility in the chemicals sector, reflecting investor reliance on quarterly performance metrics over operational news. Specific operational drivers are not disclosed in the text, preventing detailed assessment of how these gains impact DuPont's long-term competitive position.
103 articles
DuPont, Fiserv, and Revvity emerged as top S&P 500 gainers, while Gartner and Sysco led losers, with movements attributed to recent earnings reports and business developments.
DuPont de Nemours swung to a profit and raised its annual outlook following higher sales. It now anticipates adjusted earnings of $7.47 to $7.52 per share.
Asset Management One raised its DuPont stake by 19.2% to 103,663 shares worth $13.5 million. Institutional ownership reached 73.96% as DuPont beat earnings and declared a $0.60 quarterly dividend.
Shares of DuPont de Nemours Inc. rose 1.04% to $137.67, outperforming the broader market despite remaining 12.86% below its 52-week high.
Brookmont Capital Management increased its stake in DuPont de Nemours by 146.8% in Q3, acquiring 23,581 shares valued at approximately $5.15 million.
Quadrant Capital Group LLC increased its stake in DuPont de Nemours by 230.6% in Q3, while the company reported stronger-than-expected earnings and a $0.60 dividend.
Robeco Institutional Asset Management increased its stake in DuPont de Nemours by 16.4% in Q3, adding 137,070 shares valued at $124.36 million. Analysts rate the basic materials company as a "Moderate
Prime Capital Investment Advisors LLC significantly increased its stake in DuPont de Nemours by 585.6% in Q3. The company also reported strong quarterly earnings beating estimates and declared a $0.60
Shares of DuPont de Nemours Inc. rose 2.80%, breaking a two-day losing streak and outperforming competitors during a positive market session.
Generali Investments Management Co LLC increased its stake in DuPont de Nemours by acquiring 11,084 shares in Q3, totaling 11,409 shares worth $1.48 million. The investment aligns with DuPont's strong
The State of Alaska Department of Revenue increased its DuPont holdings by 61,352 shares to over $9.7 million. The company also reported earnings beating expectations and declared a $0.60 quarterly di
Iams Wealth Management LLC increased its stake in DuPont de Nemours by 174.2% in Q3, acquiring 16,038 shares valued at $3.28 million. Analysts rate the company a Moderate Buy following strong quarterl
Barclays initiated coverage on DuPont de Nemours with an overweight rating and $156 price target, following quarterly earnings that exceeded expectations with $1.88 EPS.
Farther Finance Advisors LLC increased its stake in DuPont de Nemours by 839.5% in Q3, holding $5.1 million worth of shares while the company reported a 4% year-over-year revenue increase.
DuPont de Nemours shares gain following a recent spin-off, now operating in Healthcare & Water Technologies and Diversified Industrials segments with an analyst price target of $130.
J.P. Morgan downgraded DuPont and Illinois Tool Works to Neutral from Overweight, reducing price targets to $145 and $277 respectively due to concerns over decelerating short-cycle industrial demand p
JPMorgan Chase downgraded DuPont de Nemours to "neutral" with a $145 price target, despite the company beating quarterly earnings with $1.88 EPS and $1.82 billion in revenue. Analyst consensus remains
DuPont shares rose 1.98% to $133.28 ahead of its Q3 2026 earnings report on November 3. Analysts maintain a "Moderate Buy" rating following last quarter's adjusted EPS of $1.88.
DuPont shares rose 1.13% following Wells Fargo's reaffirmed Buy rating and $166 target. The stock gained ground after reporting a 48% Q2 2026 EPS increase, offsetting impacts from a $455 million PFAS
DuPont de Nemours received a consensus "Moderate Buy" rating with a $166.60 price target after exceeding quarterly earnings and revenue estimates. While institutional ownership is high, some analysts
DuPont de Nemours Inc. shares advanced 1.14% to $131.71, outperforming the S&P 500 and Dow Jones indices. This gain snapped a two-day losing streak for the chemical manufacturer.
Jefferies raised its price target for DuPont to $177 with a Buy rating following strong Q2 results. The company reported a 48% increase in adjusted EPS to $1.88 and a 4% rise in revenue year-over-year
DuPont de Nemours shares rose after Q2 2026 earnings beat consensus with $1.88 EPS and 4% revenue growth. Positive dividend signals and analyst outlook drove investor confidence despite cyclical marke
DuPont stock is recommended for its focus on innovation and acquisitions in healthcare and water, despite challenges from construction demand and rising oil and gas input costs.
Corient Private Wealth LP reduced its stake in DuPont de Nemours by 66.8% in Q2 2026, despite the company reporting strong earnings of $1.88 EPS and announcing a $0.60 quarterly dividend.
DuPont de Nemours has launched Tyvek with Renewable Attribution, offering 30%–100% renewable content certified by ISCC PLUS. This drop-in solution supports customer ESG targets with up to 30% CO2 redu
Allworth Financial LP cut its DuPont de Nemours stake by 68.6% in Q2 to hold $789,000 worth of shares. Despite this reduction, other institutions increased positions, and analysts maintain a Moderate
Engineers Gate Manager LP reduced its DuPont stake by 55.6% in Q2, selling 35,053 shares. DuPont reported strong Q2 earnings of $1.88 per share, exceeding estimates with 4% revenue growth.
Chemours, DuPont, and Corteva agreed to a $455 million settlement with North Carolina communities regarding PFAS contamination leaks from Chemours' Fayetteville facility. Payments will be distributed
Sequoia Financial Advisors LLC reduced its DuPont stake by 64.2% to $45.07 million in Q2. DuPont reported strong quarterly earnings beating estimates, with analysts maintaining a Moderate Buy rating.
ChemBrief